// you’re reading...

Diabetes Treatment

Zafgen’s IND for diabetes treatment placed on hold by FDA

By ⋅ November 27, 2018 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment


Boston Business Journal

Zafgen's IND for diabetes treatment placed on hold by FDA
MarketWatch
Zafgen Inc. ZFGN, -40.55% said Monday the Food and Drug Administration ha placed a clinical hold on its investigational new drug application (IND) for the biopharmaceutical company's first U.S. clinical trial of its type 2 diabetes treatment, citing …
Officials with FDA Halt US Trials for Diabetes DrugPharmacy Times
Zafgen shares cut in half after FDA halts diabetes drug trialBoston Business Journal
Trending News Today: FDA Halts US Trials for Diabetes DrugSpecialty Pharmacy Times
BioSpace (press release) (blog) –Schaeffers Research (blog)
all 49 news articles »

More details can be found at www.diabeteshowto.com

Discussion

Comments are disallowed for this post.

Comments are closed.

Tag Cloud

DIABETES Diabetes Symptoms Diabetes Treatment DIET EXERCISE GESTATIONAL Gestational Diabetes glucose tolerance test Juvenile Diabetes TYPE 2

Most Emailed